By Iain Gilbert
Date: Monday 28 Oct 2024
(Sharecast News) - Medical device developer Belluscura said on Monday that group revenue had continued to in the nine months ended 26 September.
Belluscura said year-to-date revenue was better than expected at $3.3m and stated Q4 prospects had been "enhanced" by the forthcoming release of its new DISCOV-R device, with sales...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news